|
|
|
Article Cited by others ORIGINAL ARTICLE
Quinalizarin, a specific CK2 inhibitor, reduces cell viability and suppresses migration and accelerates apoptosis in different human lung cancer cell lines
Zhou Y, Li K, Zhang S, Li Q, Li Z, Zhou F, Dong X, Liu L, Wu G, Meng R
Year : 2015| Volume: 52| Issue : 6 | Page no: 119-124 | This article has been cited by | | 1 |
A CobaltII/CobaltIII complex of alizarin that was analyzed from the stand point of binding with DNA, for ROS generation and anticancer drug prospecting was identified as an analogue of anthracyclines |
|
| | Mouli Saha, Soumen Singha, Deblina Ghosh, Sanjay Kumar, Parimal Karmakar, Saurabh Das | | | Journal of Molecular Structure. 2022; : 133011 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Evaluation of Biological Activity of a Diazocine Derivative against
Heart Failure Using an Ischemia-Reperfusion Injury Model |
|
| | Figueroa-Valverde Lauro, Rosas-Nexticapa Marcela, López-Ramos Maria, Alvarez-Ramirez Magdalena, Mateu-Armad Maria Virginia, Díaz-Cedillo Francisco, Garcimarrero-Espino Alejandra, Lopez Gutierrez Tomas, Melgarejo-Gutierrez Montserrat | | | Drug Research. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Molecular mechanisms of quinalizarin induces apoptosis and
G0
/
G1
cell cycle of human esophageal cancer
HCE
-4 cells depends on
MAPK
,
|
|
| | Yan-Qing Zang, Yu-Qing Zhai, Yan-Yu Feng, Xue-Ying Ju, Feng Zuo | | | Environmental Toxicology. 2021; 36(2): 276 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
New series of isoxazole derivatives targeting EGFR-TK: Synthesis, molecular modeling and antitumor evaluation |
|
| | Eman T. Warda, Ihsan A. Shehata, Mahmoud B. El-Ashmawy, Nadia S. El-Gohary | | | Bioorganic & Medicinal Chemistry. 2020; 28(21): 115674 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Quinalizarin induces ROS-mediated apoptosis via the MAPK, STAT3 and NF-?B signaling pathways in human breast cancer cells |
|
| | Yan-Qing Zang, Yan-Yu Feng, Ying-Hua Luo, Yu-Qing Zhai, Xue-Ying Ju, Yu-Chao Feng, Ya-Nan Sheng, Jia-Ru Wang, Chang-Qing Yu, Cheng-Hao Jin | | | Molecular Medicine Reports. 2019; | | | [Pubmed] [Google Scholar] [DOI] | | | 6 |
A meta-analysis and bioinformatics exploration of the diagnostic value and molecular mechanism of miR-193a-5p in lung cancer |
|
| | Zu-Cheng Xie, Rui-Xue Tang, Xiang Gao, Qiong-Ni Xie, Jia-Ying Lin, Gang Chen, Zu-Yun Li | | | Oncology Letters. 2018; | | | [Pubmed] [Google Scholar] [DOI] | | | 7 |
Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT-4 and HCT 116 Cells |
|
| | Sayantani Mukherjee Chatterjee,Chetan Kumar Jain,Soumen Singha,Piyal Das,Susanta Roychoudhury,Hemanta Kumar Majumder,Saurabh Das | | | ACS Omega. 2018; 3(8): 10255 | | | [Pubmed] [Google Scholar] [DOI] | | | 8 |
Association of protein kinase CK2 inhibition with cellular radiosensitivity of non-small cell lung cancer |
|
| | Qianwen Li,Ke Li,Tianyang Yang,Sheng Zhang,Yu Zhou,Zhenyu Li,Jinrong Xiong,Fangzheng Zhou,Xiaoshu Zhou,Li Liu,Rui Meng,Gang Wu | | | Scientific Reports. 2017; 7(1) | | | [Pubmed] [Google Scholar] [DOI] | | | 9 |
Sphingosine kinase 1 mediates diabetic renal fibrosis via NF-?B signaling pathway: involvement of CK2a |
|
| | Junying Huang, Jingyan Li, Zhiquan Chen, Jie Li, Qiuhong Chen, Wenyan Gong, Peiqing Liu, Heqing Huang | | | Oncotarget. 2017; 8(51): 88988 | | | [Pubmed] [Google Scholar] [DOI] | | | 10 |
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target |
|
| | Melissa Chua,Charina Ortega,Ayesha Sheikh,Migi Lee,Hussein Abdul-Rassoul,Kevan Hartshorn,Isabel Dominguez | | | Pharmaceuticals. 2017; 10(4): 18 | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
